.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Avexia is stocked at 624 licensed dispensaries across Illinois, New Jersey, and 8 other states, 178 of them in Illinois, with the deepest coverage in Chicago, Springfield, Naperville, Normal, and Peoria. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Avexia’s mix in July 2026 tilted toward Topical at 48.07% share, even as Topical sales were down 20.40% year over year and 9.70% month over month, while Capsules held 27.01% share with sales down 27.18% year over year but up 5.01% month over month. Concentrates at 16.81% share fell 63.57% year over year yet rose 22.03% month over month, and Tincture & Sublingual at 8.11% share declined 37.60% year over year but increased 14.22% month over month; with average price down 6.94% year over year and the brand ranked 1 in Topical in Illinois, the pattern implies Avexia is leaning on a dominant Topical position while recovering demand pockets are emerging in faster-moving but smaller categories.
The contrast between double-digit year-over-year declines in Topical at 20.40% and Capsules at 27.18% versus double-digit month-over-month gains in Concentrates at 22.03% and Tincture & Sublingual at 14.22% indicates mix pressure from legacy pillars alongside short-cycle trial in smaller formats; combined with a 9.70% month-over-month dip in Topical and a 5.01% rise in Capsules, the near-term trajectory favors incremental share shift toward non-Topical lines. Given the 1 rank in Illinois Topical and a brand-level year-over-year sales decline of 36.15%, the implication is that defending Topical leadership while accelerating momentum in Concentrates and Tincture & Sublingual is the clearest path to stabilize mix without over-relying on price cuts.
Competitive Landscape
Avexia sits at #1 in IL Topical in July 2026 and held #1 a year ago, with no rank change YoY, while its 3-month position also remained #1, implying stability at the top as others shuffled below; Doctor Solomon's stayed at #2 while posting a -33.9% YoY sales decline, and Nature's Grace and Wellness held #3 with a 3.6% YoY increase, indicating Avexia’s moat is more about rivals’ underperformance than share-grabbing surges. With Alchemy (Ieso) fixed at #4 alongside a -12.3% YoY sales change and Alluris Wellness improving from #6 to #5 on a -7.6% YoY decline, the leaderboard shows downward pressure among challengers rather than upward momentum, which implies Avexia’s unchanged #1 rank is sustained by competitor contraction and that future risk concentrates in any rival able to convert modest gains into rank movement.
Notable Products
CBD/THC 1:1 Harmony Pain Relief Lotion (100mg CBD, 100mg THC, 2oz) fell 12.8% month over month to rank 5 in July 2026, while the CBD/THC 1:1 Harmony Pain Relief Balm (100mg CBD, 100mg THC, 2oz) slipped 5.3% but held rank 1. Four of the top ten are Capsules SKUs, yet the leading Capsules mover, CBD/THC 4:1 Relief Tablets 40-Pack (400mg CBD, 100mg THC), rose 19.6% to rank 2 compared with the Purple Lemon Punch RSO Syringe (0.5g) up 47.1% at rank 7, indicating growth sits outside the very top slots. The CBD/THC 1:1 Strawberry Orange Cream Tincture (100mg CBD, 100mg THC, 30ml) advanced 27.0% to rank 8 while Harvest Apple Tincture (100mg) climbed 35.4% to rank 10, and the category shift contrasts with the Topical leader’s $217,042 in sales softening. The pattern implies Avexia’s mix is tilting from Topicals dominance toward diversified gains in Capsules and Tincture & Sublingual, with faster percentage growth occurring in mid-table ranks rather than at the very top.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
